Business
BioHemp International, Inc (OTC: BKIT) Appoints Ryan Fishoff as Lead Advisor to Company to Assist With CBD Distribution Consolidation Focus
BioHemp International, Inc (OTC: BKIT) Appoints Ryan Fishoff as Lead Advisor to Company to Assist With CBD Distribution Consolidation Focus.
About this update from American Premium Water Corporation
[{"type":"text","content":"\nNEW YORK, June 24, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – BioHemp International, Inc. (OTC: BKIT), (“Company”) announces that it has appointed American Premium Water Corporation (OTC: HIPH) Chief Executive Officer Ryan Fishoff as Lead Advisor to the Company. Mr. Fishoff will assist Company CEO, Daniel Blum with M&A Strategy and CBD industry knowledge as the Company begins its consolidation rollup strategy.\n Mr. Fishoff has a distinguished resumé in the public markets, having been CEO of American Premium Water for almost two years. He brings comprehensive knowledge of the CBD industry, as he has led American Premium Water to become one of the top manufacturers and marketers of consumer CBD products in the industry. Cannabis Hemp Wire has called Mr. Fishoff “The King of CBD”. Prior to his role at American Premium, Mr. Fishoff spent over six years working in an international private equity firm, CoBe Capital, where he worked on cross-border M&A deals and helped develop turnaround strategies for the CoBe’s acquisitions.  Mr. Fishoff holds a Bachelor of Sciences in Business with a concentration in finance from Boston University. He will directly advise the Company and executive management on strategy, M&A, business development, and CBD industry matters. His transactional experience in the public markets and CBD industry will be instrumental to the Company as its strategy is heavily focused on transactions to expand. Ryan Fishoff, Lead Advisor, commented “I am honored to join the Company as an advisor to assist with its ambitious strategy. Having been in the CBD industry for the past two years, I have seen firsthand that there hasn’t been a distributor that has emerged as a market leader in the space. It was clear to me early on in my tenure as CEO of HIPH that there was an opportunity to consolidate, as I have seen the number of distributors grow exponentially in my tenure, but no one has established themselves as a true market leader. I am happy to advise the Company to achieve this goal. I view this advisory position as complementary to my role at HIPH, as the Company will not be directly developing products, and I hope to help create more channels of distribution for HIPH products. I am excited to work with Daniel and the Company’s management team t...